1.
Yau
JW
,
Rogers
SL
,
Kawasaki
R
, et al
;
Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy
.
Diabetes Care
2012
;
35
:
556
564
2.
Andersen
N
,
Hjortdal
,
,
Schielke
KC
, et al
The Danish Registry of Diabetic Retinopathy
.
Clin Epidemiol
2016
;
8
:
613
619
3.
Scanlon
PH
.
The English National Screening Programme for diabetic retinopathy 2003–2016
.
Acta Diabetol
2017
;
54
:
515
525
4.
Antonetti
DA
,
Klein
R
,
Gardner
TW
.
Diabetic retinopathy
.
N Engl J Med
2012
;
366
:
1227
1239
5.
American Diabetes Association
.
Economic costs of diabetes in the U.S. in 2017
.
Diabetes Care
2018
;
41
:
917
928
6.
DCCT/EDIC Research Group
,
Aiello
LP
,
Sun
W
,
Das
A
, et al
Intensive diabetes therapy and ocular surgery in type 1 diabetes
.
N Engl J Med
2015
;
372
:
1722
1733
7.
Diabetes Prevention Program Research Group
.
The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program
.
Diabet Med
2007
;
24
:
137
144
8.
Girach
A
,
Vignati
L
.
Diabetic microvascular complications: can the presence of one predict the development of another?
J Diabetes Complications
2006
;
20
:
228
237
9.
Cheung
N
,
Rogers
S
,
Couper
DJ
,
Klein
R
,
Sharrett
AR
,
Wong
TY
.
Is diabetic retinopathy an independent risk factor for ischemic stroke?
Stroke
2007
;
38
:
398
401
10.
Xie
J
,
Ikram
MK
,
Cotch
MF
, et al
Association of diabetic macular edema and proliferative diabetic retinopathy with cardiovascular disease: a systematic review and meta-analysis
.
JAMA Ophthalmol
2017
;
135
:
586
593
11.
Jeng
CJ
,
Hsieh
YT
,
Yang
CM
,
Yang
CH
,
Lin
CL
,
Wang
IJ
.
Development of diabetic retinopathy after cataract surgery
.
PLoS One
2018
;
13
:
e0202347
12.
Stem
MS
,
Hussain
M
,
Lentz
SI
, et al
Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus
.
J Diabetes Complications
2014
;
28
:
658
661
13.
Petropoulos
IN
,
Green
P
,
Chan
AW
, et al
Corneal confocal microscopy detects neuropathy in patients with type 1 diabetes without retinopathy or microalbuminuria
.
PLoS One
2015
;
10
:
e0123517
14.
Fang
C
,
Leavitt
JA
,
Hodge
DO
,
Holmes
JM
,
Mohney
BG
,
Chen
JJ
.
Incidence and etiologies of acquired third nerve palsy using a population- based method
.
JAMA Ophthalmol
2017
;
135
:
23
28
15.
Shah
AR
,
Van Horn
AN
,
Verchinina
L
, et al
Blood pressure is associated with receiving intravitreal anti-vascular endothelial growth factor treatment in patients with diabetes. Ophthalmol Retina
.
Epub ahead of print on 2 February 2019. (doi: 10.1016/j.oret.2019.01.019)
16.
Zhang
L
,
Krzentowski
G
,
Albert
A
,
Lefebvre
PJ
.
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control
.
Diabetes Care
2001
;
24
:
1275
1279
17.
Chew
EY
,
Davis
MD
,
Danis
RP
, et al
;
Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
.
Ophthalmology
2014
;
121
:
2443
2451
18.
U.K. Prospective Diabetes Study Group
.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
.
Lancet
1998
;
352
:
837
853
19.
DCCT Research Group
.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
.
N Engl J Med
1993
;
329
:
977
986
20.
Duckworth
W
,
Abraira
C
,
Moritz
T
, et al
;
VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes
.
N Engl J Med
2009
;
360
:
129
139
21.
Wong
TY
,
Cheung
CM
,
Larsen
M
,
Sharma
S
,
Simó
R
.
Diabetic retinopathy
.
Nat Rev Dis Primers
2016
;
2
:
16012
22.
DCCT/EDIC Research Group
;
Lachin
JM
,
Genuth
S
,
Cleary
P
,
Davis
MD
,
Nathan
DM
.
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
.
N Engl J Med
2000
;
342
:
381
389
23.
ACCORDION Eye Study Group and ACCORDION Study Group
.
Persistent effects of intensive glycemic control on retinopathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
.
Diabetes Care
2016
;
39
:
1089
1100
24.
Holman
RR
,
Paul
SK
,
Bethel
MA
,
Matthews
DR
,
Neil
HA
.
10-year follow-up of intensive glucose control in type 2 diabetes
.
N Engl J Med
2008
;
359
:
1577
1589
25.
American Diabetes Association
.
6. Glycemic targets: Standards of Medical Care in Diabetes—2019
.
Diabetes Care
2019
;
42
(
Suppl. 1
):
S61
S70
26.
Bain
SC
,
Klufas
MA
,
Ho
A
,
Matthews
DR
.
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review
.
Diabetes Obes Metab
2019
;
21
:
454
466
27.
Feldman-Billard
S
,
Larger
É
,
Massin
P
;
Standards for Screening and Surveillabce of Ocular Complications in People with Diabetes SFD Study Group. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes
.
Diabetes Metab
2018
;
44
:
4
14
28.
DCCT Research Group
.
Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial
.
Arch Ophthalmol
1998
;
116
:
874
886
29.
Aiello
LP
,
for the DCCT/EDIC Research Group
.
Diabetic retinopathy and other ocular findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
.
Diabetes Care
2014
;
37
:
17
23
30.
Early Treatment Diabetic Retinopathy Study Research Group
.
Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10
.
Ophthalmology
1991
;
98
(
Suppl. 5
):
786
806
31.
Li
Y
,
Ryu
C
,
Munie
M
, et al
Association of metformin treatment with reduced severity of diabetic retinopathy in type 2 diabetic patients
.
J Diabetes Res
2018
;
2018
:
2801450
32.
Oshitari
T
,
Asaumi
N
,
Watanabe
M
,
Kumagai
K
,
Mitamura
Y
.
Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study
.
Vasc Health Risk Manag
2008
;
4
:
1137
1140
33.
Dicembrini
I
,
Nreu
B
,
Scatena
A
, et al
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta- analysis of randomized controlled trials
.
Acta Diabetol
2017
;
54
:
933
941
34.
Dorsey-Treviño
EG
,
Contreras-Garza
BM
,
González-González
JG
, et al
Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol
.
BMJ Open
2018
;
8
:
e020692
35.
Mieno
H
,
Yoneda
K
,
Yamazaki
M
,
Sakai
R
,
Sotozono
C
,
Fukui
M
.
The efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study
.
BMJ Open Ophthalmol
2018
;
3
:
e000130
36.
Idris
I
,
Warren
G
,
Donnelly
R
.
Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes
.
Arch Intern Med
2012
;
172
:
1005
1011
37.
Gower
EW
,
Lovato
JF
,
Ambrosius
WT
, et al;
ACCORD Study Group
.
Lack of longitudinal association between thiazolidinediones and incidence and progression of diabetic eye disease: the ACCORD Eye Study
.
Am J Ophthalmol
2018
;
187
:
138
147
38.
Schrier
RW
,
Estacio
RO
,
Esler
A
,
Mehler
P
.
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
.
Kidney Int
2002
;
61
:
1086
1097
39.
U.K. Prospective Diabetes Study Group
.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
.
BMJ
1998
;
317
:
703
713
40.
Giusti
C
,
Forte
R
,
Vingolo
EM
,
Gargiulo
P
.
Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study
.
Int Ophthalmol
2001
;
24
:
79
88
41.
Estacio
RO
,
McFarling
E
,
Biggerstaff
S
,
Jeffers
BW
,
Johnson
D
,
Schrier
RW
.
Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM
.
Am J Kidney Dis
1998
;
31
:
947
953
42.
Chung
YR
,
Park
SW
,
Choi
SY
, et al
Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy
.
Cardiovasc Diabetol
2017
;
16
:
4
43.
Knickelbein
JE
,
Abbott
AB
,
Chew
EY
.
Fenofibrate and diabetic retinopathy
.
Curr Diab Rep
2016
;
16
:
90
44.
Hwang
H
,
Chae
JB
,
Kim
JY
,
Moon
BG
,
Kim
DY
.
Changes in optical coherence tomography findings in patients with chronic renal failure undergoing dialysis for the first time. Retina
.
Epub ahead of print on 30 August 2018 (doi: 10.1097/IAE.0000000000002312)
45.
Ong
SS
,
Thomas
AS
,
Fekrat
S
.
Improvement of recalcitrant diabetic macular edema after peritoneal dialysis
.
Ophthalmic Surg Lasers Imaging Retina
2017
;
48
:
834
837
46.
Theodossiadis
PG
,
Theodoropoulou
S
,
Neamonitou
G
, et al
Hemodialysis-induced alterations in macular thickness measured by optical coherence tomography in diabetic patients with end-stage renal disease
.
Ophthalmologica
2012
;
227
:
90
94
47.
Ciardella
AP
.
Partial resolution of diabetic macular oedema after systemic treatment with furosemide
.
Br J Ophthalmol
2004
;
88
:
1224
1225
48.
American Diabetes Association
.
4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes—2019
.
Diabetes Care
2019
;
42
(
Suppl. 1
):
S34
S45
49.
Gorman
DM
,
le Roux
CW
,
Docherty
NG
.
The effect of bariatric surgery on diabetic retinopathy: good, bad, or both?
Diabetes Metab J
2016
;
40
:
354
364
50.
Richardson
P
,
Hulpus
A
,
Idris
I
.
Short-term impact of bariatric surgery on best-corrected distance visual acuity and diabetic retinopathy progression
.
Obes Surg
2018
;
28
:
3711
3713
51.
Praidou
A
,
Harris
M
,
Niakas
D
,
Labiris
G
.
Physical activity and its correlation to diabetic retinopathy
.
J Diabetes Complications
2017
;
31
:
456
461
52.
Loprinzi
PD
,
Edwards
MK
,
Frith
E
.
Review of the literature examining the association between physical activity and retinopathy
.
Phys Sportsmed
2018
;
46
:
123
128
53.
Kassoff
A
,
Catalano
RA
,
Mehu
M
.
Vitreous hemorrhage and the Valsalva maneuver in proliferative diabetic retinopathy
.
Retina
1988
;
8
:
174
176
54.
Androudi
S
,
Ahmed
M
,
Brazitikos
P
,
Foster
CS
.
Valsalva retinopathy: diagnostic challenges in a patient with pars-planitis
.
Acta Ophthalmol Scand
2005
;
83
:
256
257
55.
Tan
NYQ
,
Chew
M
,
Tham
YC
, et al
Associations between sleep duration, sleep quality and diabetic retinopathy
.
PLoS One
2018
;
13
:
e0196399
56.
Altaf
QA
,
Dodson
P
,
Ali
A
, et al
Obstructive sleep apnea and retinopathy in patients with type 2 diabetes: a longitudinal study
.
Am J Respir Crit Care Med
2017
;
196
:
892
900
57.
Cai
X
,
Chen
Y
,
Yang
W
,
Gao
X
,
Han
X
,
Ji
L
.
The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis
.
Endocrine
2018
;
62
:
299
306
58.
Martin-Merino
E
,
Fortuny
J
,
Rivero-Ferrer
E
,
Lind
M
,
Garcia- Rodriguez
LA
.
Risk factors for diabetic macular oedema in type 2 diabetes: a case-control study in a United Kingdom primary care setting
.
Prim Care Diabetes
2017
;
11
:
288
296
59.
Bergerhoff
K
,
Clar
C
,
Richter
B
.
Aspirin in diabetic retinopathy: a systematic review
.
Endocrinol Metab Clin North Am
2002
;
31
:
779
793
60.
Shi
Y
,
Tham
YC
,
Cheung
N
, et al
Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study
.
PLoS One
2017
;
12
:
e0175966
61.
DCCT Research Group
.
Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial
.
Diabetes Care
2000
;
23
:
1084
1091
62.
Axer-Siegel
R
,
Hod
M
,
Fink-Cohen
S
, et al
Diabetic retinopathy during pregnancy
.
Ophthalmology
1996
;
103
:
1815
1819
63.
Chew
EY
,
Mills
JL
,
Metzger
BE
, et al
Metabolic control and progression of retinopathy: the Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study
.
Diabetes Care
1995
;
18
:
631
637
64.
American Diabetes Association
.
11. Microvascular complications and foot care: Standards of Medical Care in Diabetes—2019
.
Diabetes Care
2019
;
42
(
Suppl. 1
):
S124
S138
65.
Tang
J
,
Li
T
,
Li
P
, et al
Early assessment of the risk factors for diabetic retinopathy can reduce the risk of peripheral arterial and cardiovascular diseases in type 2 diabetes
.
Ophthalmic Res
2018
;
59
:
221
227
66.
Scott
A
,
Bressler
N
,
Ffolkes
S
,
Wittenborn
JS
,
Jorkasky
J
.
Public attitudes about eye and vision health
.
JAMA Ophthalmol
2016
;
134
:
1111
1118
67.
National Institute of Diabetes and Digestive and Kidney Disease
.
Diabetes statistics
.
68.
National Eye Institute
.
Cataracts. Available from nei.nih.gov/eyedata/cataract. Accessed 31 January 2019
69.
Michael
R
,
Bron
AJ
.
The ageing lens and cataract: a model of normal and pathological ageing
.
Philos Trans R Soc Lond B Biol Sci
2011
;
366
:
1278
1292
70.
Javadi
M
,
Zarei-Ghanavati
S
.
Cataracts in diabetic patients: a review article
.
J Ophthalmic Vis Res
2008
;
3
:
52
65
71.
Kinoshita
JH
,
Fukushi
S
,
Kador
P
,
Merola
LO
.
Aldose reductase in diabetic complications of the eye
.
Metabolism
1979
;
28
(
Suppl. 1
)
462
469
72.
Becker
C
,
Schneider
C
,
Aballéa
S
, et al
Cataract in patients with diabetes mellitus: incidence rates in the UK and risk factors
.
Eye (Lond)
2018
;
32
:
1028
1035
73.
Lindstrom
R
Thoughts on cataract surgery: 2015. Review of Ophthalmology 9 March 2015
.
74.
Davis
G
The evolution of cataract surgery
.
Mo Med
2016
;
113
:
58
62
75.
Steinle
NC
,
Lampen
SIR
,
Wykoff
CC
.
Editorial: the intersection of diabetes mellitus and cataract surgery: current state of management
.
Ophthalmol Retina
2018
;
2
:
83
85
76.
Wu
S
,
Tong
N
,
Pan
L
, et al
Retrospective analyses of potential risk factors for posterior capsule opacification after cataract surgery
.
J Ophthalmol
2018
;
2018
:
9089285
77.
Herrinton
LJ
,
Shorstein
NH
,
Paschal
JF
, et al
Comparative effectiveness of antibiotic prophylaxis in cataract surgery
.
Ophthalmology
2016
;
123
:
287
294
78.
Sohn
EH
,
van Dijk
HW
,
Jiao
C
, et al
Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus
.
Proc Natl Acad Sci U S A
2016
;
113
:
E2655
E2664
79.
Gardner
TW
,
Davila
JR
.
The neurovascular unit and the pathophysiologic basis of diabetic retinopathy
.
Graefes Arch Clin Exp Ophthalmol
2017
;
255
:
1
6
80.
van Dijk
HW
,
Verbraak
FD
,
Kok
PH
, et al
Early neurodegeneration in the retina of type 2 diabetic patients
.
Invest Ophthalmol Vis Sci
2012
;
53
:
2715
2719
81.
Sun
JK
,
Radwan
SH
,
Soliman
AZ
, et al
Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema
.
Diabetes
2015
;
64
:
2560
2570
82.
Fante
RJ
,
Gardner
TW
,
Sundstrom
JM
.
Current and future management of diabetic retinopathy: a personalized evidence-based approach
.
Diabetes Manag
2013
;
3
:
481
494
83.
Klein
R
,
Knudtson
MD
,
Lee
KE
,
Gangnon
R
,
Klein
BE
.
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes
.
Ophthalmology
2009
;
116
:
497
503
84.
Kotoula
MG
,
Koukoulis
GN
,
Zintzaras
E
,
Karabatsas
CH
, and
Chatzoulis
DZ
.
Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal photocoagulation
.
Diabetes Care
2005
;
28
:
2454
2457
85.
Early Treatment Diabetic Retinopathy Study Research Group
.
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1
.
Arch Ophthalmol
1985
;
103
:
1796
-
1806
86.
Brown
DM
,
Nguyen
QD
,
Marcus
DM
, et al;
RIDE
and
RISE Research Group
.
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
.
Ophthalmology
2013
;
120
:
2013
2022
87.
Heier
JS
,
Korobelnik
JF
,
Brown
DM
, et al
Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies
.
Ophthalmology
2016
;
123
:
2376
2385
88.
Diabetic Retinopathy Clinical Research Network
,
Wells
JA
,
Glassman
AR
,
Ayala
AR
, et al
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
.
N Engl J Med
2015
;
372
:
1193
1203
89.
Boyer
DS
,
Yoon
YH
,
Belfort
R
 Jr
, et al;
Ozurdex MEAD Study Group
.
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
.
Ophthalmology
2014
;
121
:
1904
1914
90.
Campochiaro
PA
,
Brown
DM
,
Pearson
A
, et al;
FAME Study Group
.
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema
.
Ophthalmology
2012
;
119
:
2125
2132
91.
Writing Committee for the UK Age-Related Macular Degeneration EMR User Group
.
The neovascular age-related macular degeneration database: multicenter study of 92,976 ranibizumab injections: report 1: visual acuity
.
Ophthalmology
2014
;
121
:
1092
1101
92.
Ho
AC
,
Albini
TA
,
Brown
DM
,
Boyer
DS
,
Regillo
CD
,
Heier
JS
.
The potential importance of detection of neovascular age-related macular degeneration when visual acuity is relatively good
.
JAMA Ophthalmol
2017
;
135
:
268
273
93.
Nguyen
QD
,
Brown
DM
,
Marcus
DM
, et al
;
RISE and RIDE Research Group. Ranibizumab for diabetic mecular edema: results from 2 phase III randomized trials: RISE and RIDE
.
Ophthalmology
2012
;
119
:
789
801
94.
Korobelnik
JF
,
Do
DV
,
Schmidt-Erfurth
U
, et al
Intravitreal aflibercept for diabetic macular edema
.
Ophthalmology
2014
;
121
:
2247
2254
95.
Wells
JA
,
Glassman
AR
,
Ayala
AR
, et al
;
Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial
.
Ophthalmology
2016
;
123
:
1351
1359
96.
Bressler
NM
,
Beaulieu
WT
,
Glassman
AR
, et al
;
Diabetic Retinopathy Clinical Research Network. Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial
.
JAMA Ophthalmol
2018
;
136
:
257
269
97.
Maturi
RK
,
Glassman
AR
,
Liu
D
, et al
;
Diabetic Retinopathy Clinical Research Network. Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR Network phase 2 randomized clinical trial
.
JAMA Ophthalmol
2018
;
136
:
29
38
98.
Boyer
DS
,
Nguyen
QD
,
Brown
DM
,
Basu
K
,
Ehrlich
JS
;
RIDE
and
RISE Research Group
.
Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials
.
Ophthalmology
2015
;
122
:
2504
2513
99.
Wykoff
CC
,
Ou
WC
,
Khurana
RN
,
Brown
DM
,
Lloyd Clark
W
,
Boyer
DS
;
ENDURANCE Study Group
.
Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study
.
Br J Ophthalmol
2018
;
102
:
631
636
100.
Diabetic Retinopathy Study Research Group
.
Preliminary report on effects of photocoagulation therapy
.
Am J Ophthalmol
1976
;
81
:
383
396
101.
Gross
JG
,
Glassman
AR
,
Liu
D
, et al
;
Diabetic Retinopathy Clinical Research Network. Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial
.
JAMA Ophthalmol
2018
;
136
:
1138
1148
102.
Ip MS, Domalpally A, Hopkins JJ,Wong P, Ehrlich JS. Long-term effects of ranibizumab on diabetic retinopathy severity and progression
.
Arch Ophthalmol
2012
;
130
:
1145
1152
103.
Wykoff
CC
,
Chakravarthy
U
,
Campochiaro
PA
,
Bailey
C
,
Green
K
,
Cunha-Vaz
J
.
Long-term effects of intravitreal 0.19 mg fluocinolone acetonide implant on progression and regression of diabetic retinopathy
.
Ophthalmology
2017
;
124
:
440
449
104.
Wykoff
CC
,
Eichenbaum
DA
,
Roth
DB
,
Hill
L
,
Fung
AE
,
Haskova
Z
.
Ranibizumab induces regression of diabetic retinopathy in most patients at high risk of progression to proliferative diabetic retinopathy
.
Ophthalmol Retina
2018
;
2
:
997
1009
105.
Campochiaro
PA
,
Wykoff
CC
,
Shapiro
H
,
Rubio
RG
,
Ehrlich
JS
.
Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema
.
Ophthalmology
2014
;
121
:
1783
1789
106.
ClinicalTrials.gov. Study of the efficacy and safety of intravitreal (IVT) aflibercept for the improvement of moderately severe to severe nonproliferative diabetic retinopathy (NPDR) (PANORAMA). Available from clinicaltrials.gov/ct2/show/NCT02718326. Accessed 25 January 2019
107.
107
ClinicalTrials.gov
Anti-VEGF treatment for prevention of PDR/ DME. Available from clinicaltrials.gov/ct2/show/NCT02634333. Accessed 25 January 2019
108.
Wallick
CJ
,
Hansen
RN
,
Campbell
J
,
Kiss
S
,
Kowalski
JW
,
Silluvan
SD
.
Comorbidity and health care resource use among commercially insured non-elderly patients with diabetic macular edema
.
Ophthalmic Surg Lasers Imaging Retina
2015
;
46
:
744
751
109.
Holekamp
NM
,
Campbell
J
,
Almony
A
, et al
Vision outcomes following anti-vascular endothelial growth factor treatment of diabetic macular edema in clinical practice
.
Am J Ophthalmol
2018
;
191
:
83
91
110.
Obeid
A
,
Gao
X
,
Ali
FS
, et al
Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections
.
Ophthalmology
2018
;
125
:
1386
1392
111.
American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019
.
Diabetes Care
2019
;
42
(
Suppl. 1
):
S46
S60
112.
Hendrieckx
C
,
Halliday
JA
,
Beeney
LJ
,
Speight
J
.
Diabetes and Emotional Health: A Handbook for Health Professionals Supporting Adults with Type 1 or Type 2 Diabetes
.
Canberra, Australia
,
National Diabetes Services Scheme
,
2016
113.
Powers
MA
,
Bardsley
J
,
Cypress
M
, et al
Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics
.
Diabetes Care
2015
;
38
:
1372
1382
114.
Ferrari
AJ
,
Somerville
AJ
,
Baxter
AJ
, et al
Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature
.
Psychol Med
2013
;
43
:
471
481
115.
Nicolucci
A
,
Kovacs Burns
K
,
Holt
RI
, et al;
DAWN2 Study Group
.
Diabetes Attitudes, Wishes and Needs Second Study (DAWN2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes
.
Diabet Med
2013
;
30
:
767
777
116.
National Eye Institute
.
Health education leads to more eye exams in group at risk for vision loss
.
Available from nei.nih.gov/news/pressreleases/morexam. Accessed 29 January 2019
117.
Dickinson
JK
,
Guzman
SJ
,
Maryniuk
MD
, et al
The use of language in diabetes care and education
.
Diabetes Care
2017
;
40
:
1790
1799
118.
Wardian JL. Diabetes cannot be controlled, but it can be managed
.
Clin Diabetes
2017
;
35
:
329
330
119.
NHS England
.
Language Matters: Language and Diabetes
.
120.
Dickinson
JK
,
Maryniuk
MD
.
Building therapeutic relationships: choosing words that put people first
.
Clin Diabetes
2017
;
35
:
51
54
121.
Solomon
SD
,
Chew
E
,
Duh
EJ
, et al
Diabetic retinopathy: a position statement by the American Diabetes Association
.
Diabetes Care
2017
;
40
:
412
418
122.
Aiello
LP
,
Gardner
TW
,
King
GL
, et al
Diabetic retinopathy
.
Diabetes Care
1998
;
21
:
143
156
123.
An
J
,
Niu
F
,
Turpcu
A
,
Raiput
Y
,
Cheetham
TC
.
Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States
.
Ophthalmic Epidemiol
2018
;
25
:
257
265
124.
Prentki
M
,
Nolan
CJ
.
Islat beta cell failure in type 2 diabetes
.
J Clin Invest
2006
;
116
:
1802
1812
125.
Chen
X
,
Seth
RK
,
Rao
VS
,
Huang
JJ
,
Adelman
RA
.
Effects of music therapy on intravitreal injections: a randomized clinical trial
.
J Ocul Pharmacol Ther
2012
;
28
:
414
419

The opinions expressed are those of the authors and do not necessarily reflect those of Genentech or the American Diabetes Association. The content was developed by the authors and does not represent the policy or position of the American Diabetes Association, any of its boards or committees, or any of its journals or their editors or editorial boards.

To request permission to reuse or reproduce any portion of this publication, please contact permissions@diabetes.org.

Suggested citation:

Gardner TW, Wyckoff JA, Shah AR, et al. Prevention and Management of Diabetes-Related Eye Disease. Arlington, Va., American Diabetes Association, 2019.

Dualities of Interest

T.W.G. has received research support from Zebra Biologics and consulting fees from Novo Nordisk.

C.C.W. has received research support from Adverum, Allergan, Apellis, Clearside, Genentech, Roche, Neurotech, Novartis, Opthea, Regeneron, Regenxbio, Samsung, and Santen; is a consultant for Adverum, Alimera Sciences, Allegro, Allergan, Apellis, Bayer, Clearside, EyePoint, Genentech, Kodiak, Novartis, Regeneron, Regenxbio, and Roche; and is a speaker for Regeneron.

B.A.C. has been a speaker for Novo Nordisk and served on an advisory board for Regeneron.

No other potential conflicts of interest relevant to this compendium were reported.

Acknowledgments

Editorial and project management services were provided by Debbie Kendall of Kendall Editorial in Richmond, VA.

Author Contributions

All authors researched and wrote their respective sections. Lead author T.W.G. reviewed all content and is the guarantor of this work.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.

Article PDF first page preview

Article PDF first page preview